Follistatin (FST) Peptide
FST
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN977116
Quick Overview for Follistatin (FST) Peptide (ABIN977116)
Target
Follistatin (FST)
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-FST antibody (Catalog #: ARP42287_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Follistatin (FST)
-
Background
-
Follistatin is a single-chain gonadal protein that specifically inhibits follicle-stimulating hormone release.Follistatin is a single-chain gonadal protein that specifically inhibits follicle-stimulating hormone release. The single FST gene encodes two isoforms, FST317 and FST344 containing 317 and 344 amino acids respectively, resulting from alternative splicing of the precursor mRNA. In a study in which 37 candidate genes were tested for linkage and association with polycystic ovary syndrome (PCOS) or hyperandrogenemia in 150 families, evidence was found for linkage between PCOS and follistatin.
Alias Symbols: FS
Protein Interaction Partner: BMP5,FN1,INHA,INHBA,INHBE,INHBE,TXN
Protein Size: 317 -
Molecular Weight
- 35 kDa
-
Gene ID
- 10468
-
NCBI Accession
- NM_006350, NP_006341
-
UniProt
- Q6FHE1
Target
-
You are here:
